5:45 Recent Study on Combination of Guselkumab and Golimumab in Ulcerative Colitis March 3, 2022 • Ulcerative Colitis Content Hub Bruce Sands, MD, MS, from @IcahnMountSinai, discusses a combination therapy in #ulcerativecolitis.
2:41 Use of Electronic Health Records to Assess Risk for Lysosomal Storage Disease February 23, 2022 • Pompe Disease Content Hub @DNADirectedDawn, of @EmoryGCTP, discusses severity #scoring systems as #screening for #lysosomalstoragediseases.
4:35 Safety and Efficacy of Asciminib in Third-Line Treatment for CML January 30, 2022 • CML Content Hub @mjmauroMD, of @MSKCancerCenter, discusses #third-line treatment for #CML.
2:12 Well Tolerated in Preliminary Study: Pembrolizumab + TKIs in CML Patients With Persistent Detectible MRD January 19, 2022 • CML Content Hub @Dr_AmerZeidan, of @Yale, discusses #safety of #pembrolizumab plus #TKIs in #CML.
2:00 Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Did Not Meet Noninferiority Compared to Coronary Artery Bypass Surgery December 23, 2021 • Cardiology Dr William Fearon of @StanfordUniversity discusses FAME3 trial outcomes.
3:12 Pancreatic Islet Transplantation: A New Cure for Type 1 Diabetes? October 29, 2021 • Endocrinology Dr Philip O'Connell from Westmead Institute provides insights into the potential for curing type 1 diabetes with pancreatic islet cell transplants.
10:04 Long-Term Follow-Up of POUT August 2, 2021 • Oncology Alison Birtle, MD, of @LancsHospitals, discusses updated results from the #POUT study, demonstrating increased #DFS with #chemo in #UTUC.
3:54 Immune Checkpoint Inhibitors in Upper and Lower Tract Urothelial Carcinoma August 2, 2021 • Oncology @PGrivasMDPhD, from @SeattleCCA @UWDeptMedicine @fredhutch, discusses outcomes of #ICI therapy in #UTUC vs LTUC.
14:10 Data Updates From ASCO 2021 August 2, 2021 • Oncology @amerseburger and @ERPlimackMD discuss data presented at #ASCO2021 on #urothelialcarcinoma.
1:49 Association Between Angiotensin Blockade and Response to PD-1/L1 Inhibition in Metastatic Urothelial Carcinoma August 1, 2021 • Oncology @sonpavde, of @DanaFarber_GU, discusses the effects of #angiotensin blockade on #PD-1/L1 inhibition in #metastatic #urothelialcarcinoma.
